Oxytocin Dosing Protocol: 5 mg Vial — Social Bonding & Anti-Inflammatory Guide
Compounded oxytocin 5 mg vial: off-label subcutaneous amounts used by clinics, reconstitution math, and what the research has and hasn't shown.
Quickstart highlights
Oxytocin is a nine-amino-acid hormone (molecular weight 1007.19, per the Pitocin label) that binds the oxytocin receptor in the uterus, breast tissue and brain.
- Oxytocin is FDA-approved only for labor and postpartum bleeding (Pitocin). Subcutaneous use for mood, social or sexual goals is off-label.
- 5 mg vial + 2.5 mL bacteriostatic water = 2 mg/mL: 50 µg = 2.5 units, 100 µg = 5 units on a U-100 syringe.
- The 50–100 µg every-other-day amounts are off-label clinic practice, not trial doses.
- At every other day, 14 doses fit in the 28-day use window, so a 12-week course uses 3 vials.
- Most research used 18–40 IU intranasally, and results for anxiety, trust and sexual function have been weak or negative.
Dosing table
For educational reference only. Your prescribing provider may adjust doses based on your clinical profile and response.
| Week | Dose (µg) | Units | Frequency | Notes |
|---|---|---|---|---|
| 1-4 | 50 | 2.5 | Every other day | Off-label clinic practice, not from a trial. 50 µg ≈ 29 IU (1 IU ≈ 1.71 µg) = 2.5 units on a U-100 syringe at 2 mg/mL. The vial holds 100 doses at this amount, but only 14 every-other-day doses fit in the 28-day use window. |
| 5-12 | 100 | 5 | Every other day | Off-label clinic practice, not from a trial. 100 µg ≈ 58 IU = 5 units at 2 mg/mL. The vial holds 50 doses at this amount; 14 fit in the 28-day window. |
Your free Oxytocin tracker
- Dose reminders
- Injection logging
- Cycle progress
Reconstitution steps
- Add 2.5 mL bacteriostatic water, running it slowly down the vial wall.
- Swirl gently until dissolved; do not shake.
- Final concentration: 2 mg/mL. On a U-100 insulin syringe, 50 µg = 2.5 units and 100 µg = 5 units.
- To convert to IU: a pharmacokinetic study gave 400 IU as 684 µg (1 IU ≈ 1.71 µg), so 100 µg ≈ 58 IU. Check the pharmacy label, since a compounded product's potency can differ.
- Label with the date; refrigerate at 2–8 °C and use within 28 days, or by the pharmacy's beyond-use date if earlier.
Supplies needed
8-week plan
- 2 vials
- 28 syringes
- 5 mL bac water
- 28 alcohol swabs
12-week plan
- 3 vials
- 42 syringes
- 7.5 mL bac water
- 42 alcohol swabs
Protocol overview & cycle notes
Reference schedule and reconstitution math for a compounded 5 mg oxytocin vial. Oxytocin is FDA-approved only for obstetric use; subcutaneous dosing for anxiety, social or sexual goals is off-label clinic practice with no trial-established dose.
Off-cycle: Not established. Clinic protocols describe 8–12 week courses followed by breaks; no study has tested course length or whether breaks are needed.
Storage & handling
Injection & tracking tips
- Clinic protocols use subcutaneous injection into abdominal fat. No study has tested a subcutaneous schedule for mood or social effects, and no study shows that every-other-day spacing prevents receptor desensitization.
- The only subcutaneous oxytocin trial we found used 4 µg as a single local injection to test heat pain; it reduced pain only on the injected arm.
- In a pharmacokinetic study, intranasal oxytocin had about 0.7% bioavailability with large person-to-person variation. How much oxytocin reaches the brain after subcutaneous injection has not been measured.
- Do not use oxytocin if you are or may be pregnant; its approved use is to make the uterus contract.
Tracking
Logging helps you and your provider spot patterns and adjust dose or timing.
- Rate anxiety or social comfort weekly on a consistent scale; in controlled trials, placebo groups often improved about as much as oxytocin groups.
- Track sexual function on a consistent scale if that is your goal.
- Note headaches, nausea, swelling or reduced urination and report them to the prescriber; oxytocin has a water-retaining effect at high doses.
How this works & references
Sources
- Shafer SL, et al. Plasma pharmacokinetics of intravenous and intranasal oxytocin in nonpregnant adults. Br J Anaesth. 2025. PMID: 40121179
- De Groot AN, et al. Bioavailability and pharmacokinetics of sublingual oxytocin in male volunteers. J Pharm Pharmacol. 1995. PMID: 8568623
- Albinni B, et al. Subcutaneous Oxytocin Injection Reduces Heat Pain: A Randomized-Controlled Trial. J Pain. 2024. PMID: 38642595
- MacDonald E, et al. A review of safety, side-effects and subjective reactions to intranasal oxytocin in human research. Psychoneuroendocrinology. 2011. PMID: 21429671
- Declerck CH, et al. A registered replication study on oxytocin and trust. Nat Hum Behav. 2020. PMID: 32514040
- Sikich L, et al. Intranasal Oxytocin in Children and Adolescents with Autism Spectrum Disorder. N Engl J Med. 2021. PMID: 34644471
- Lopes S, et al. Effects of intranasal oxytocin on pain perception among human subjects: A systematic literature review and meta-analysis. Horm Behav. 2023. PMID: 36463692
- Bakermans-Kranenburg MJ, et al. Sniffing around oxytocin: review and meta-analyses of trials in healthy and clinical groups with implications for pharmacotherapy. Transl Psychiatry. 2013. PMID: 23695233
Frequently asked questions
What is the oxytocin peptide dosage?
Is the oxytocin dose different for men and women?
How do I convert oxytocin IU to mg?
Is subcutaneous oxytocin more effective than intranasal?
Does oxytocin cause uterine contractions?
Can oxytocin help with pain?
Related protocols
KLOW Blend Dosing Protocol — BPC-157, TB-500, KPV & GHK-Cu Guide
KLOW peptide blend (BPC-157 + TB-500 + KPV + GHK-Cu) dosing guide for tissue repair, anti-inflammatory support, and extracellular matrix remodeling — the GLOW blend plus KPV.
View protocolGLOW Blend Dosing Protocol — BPC-157, TB-500 & GHK-Cu Skin & Repair Guide
GLOW peptide blend (BPC-157 + TB-500 + GHK-Cu) dosing guide for tissue repair, angiogenesis, and collagen and connective-tissue remodeling.
View protocolVilon Dosing Protocol: 20 mg Vial — Dipeptide Immune & Longevity Bioregulator Guide
Vilon (Lys-Glu dipeptide) bioregulator: community-reported dosing, reconstitution math for the 20 mg vial, and what the research does and doesn't support.
View protocolVesugen Dosing Protocol: 20 mg Vial — Vascular Bioregulator & Cardiovascular Guide
Vesugen (Lys-Glu-Asp tripeptide) Russian vascular bioregulator dosing guide — endothelial cell gene normalization for arterial health, blood pressure regulation, and cardiovascular aging.
View protocolThis content is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting any peptide therapy. Dosing and protocols may vary by formulation and prescriber.
